Trial Profile
A phase III study of ladostigil in patients with mild cognitive impairment
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 29 Jul 2015
Price :
$35
*
At a glance
- Drugs Ladostigil (Primary)
- Indications Mild cognitive impairment
- Focus Therapeutic Use
- 29 Jul 2015 New trial record